Medical Microbiology articles for University of Oxford, United Kingdom (UK)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 39

Article ‘Count’ for Medical Microbiology.

Journal Count Share
1 0.05
Pseudomonas aeruginosa in patients with Nosocomial Respiratory Infections: A secondary analysis of the European Network for ICU-Related Respiratory Infections (ENIRRIs). 0.05
1 0.04
Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial 0.04
1 0.06
The Disease Burden of Helicobacter pylori Beyond Gastric Cancer: Quantifying the Forgotten Potential Benefits of Mass Eradication 0.06
1 0.03
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions 0.03
1 0.69
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies. 0.69
1 0.04
A thiadiazolylidene-morpholine compound inhibits Pseudomonas aeruginosa by destabilizing the thiamine monophosphate kinase thiL 0.04
1 0.11
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2 0.11
5 0.75
Investigation of correlates of protection against gonococcal infection by comparative immunoprofiling of responses in experimental and clinical studies 0.39
Anti-spike IgG Avidity Enhances Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2: A Prospective Study of Primary Infections and Immunizations 0.09
Age-Specific Concentrations and Seroprevalence of Antibodies Against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) Across 3 Sites in Kenya 0.13
False-positive malaria rapid diagnostic tests are prevalent among children under 5 years of age in Uganda 0.07
Leptospirosis Prevalence and Risk Factors Among Patients Presenting With Fever to 4 Healthcare Sites in Sub-Saharan Africa and South East Asia: An International Multisite Observational and Nested Case–Control Study 0.07
2 0.14
Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells 0.08
Pre-assembly of biomolecular condensate seeds drives RSV replication 0.07
12 3.26
Host oxidative stress primes mycobacteria for rapid antibiotic resistance evolution 0.04
The Mycobacterium abscessus cytochrome bcc:aa3 oxidase structure paves the way for an agent targeting subunit QcrB 0.04
Differential gut transmission of IncP plasmid clades involving hypervirulent reveals plasmid-specific ecological adaptation 0.04
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease 0.12
A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept study 0.13
Escherichia coli phylogeny drives co-amoxiclav resistance through variable expression of TEM-1 beta-lactamase 0.33
Episomal and integrated hepatitis B transcriptome mapping uncovers heterogeneity with the potential for drug-resistance 0.84
The structure of the mammalian bornavirus polymerase complex 0.70
Microhaplotype deep sequencing assays to capture infection lineages 0.07
Acquisition of carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in Niger 0.26
Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine 0.66
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants 0.03
1 0.17
Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: A modelling study 0.17
1 0.37
The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus 0.37
1 0.10
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo 0.10
1 0.25
Structural basis for EtfD-mediated coupling of β-oxidation and the respiratory chain in mycobacteria 0.25
1 0.50
Everything is everywhere but Escherichia coli adapts to different niches 0.50
1 0.04
Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme 0.04
2 0.33
Health-economic impacts of age-targeted and sex-targeted Lassa fever vaccination in endemic regions of Nigeria, Guinea, Liberia, and Sierra Leone: a modelling study 0.32
7-year trend of timely hepatitis B birth dose vaccination coverage in The Gambia: a retrospective, population-based analysis 0.00
1 0.02
Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial 0.02
3 0.46
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients 0.29
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine 0.15
Marburg Virus Disease in Rwanda, 2024 — Public Health and Clinical Responses 0.01
1 0.10
Real-world effectiveness and safety of nirsevimab, RSV maternal vaccine and RSV vaccines for older adults: a living systematic review and meta-analysis 0.10

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.